JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 14 No. 11 793-797
© 1973 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billinghurst, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billinghurst, M. W.

Chromatographic Quality Control of 99mTc-Labeled Compounds

M. W. Billinghurst

Winnipeg General Hospital, Winnipeg, Manitoba, Canada

Correspondence: For reprints contact: M. W. Billinghurst, Section of Nuclear Medicine, Health Sciences Center, 700 Willow Ave., Winnipeg, Manitoba, Canada.

ABSTRACT

The increasingly general use of a number of 99mTc-labeled compounds makes the need for an understanding of the capabilities of simple quality-control procedures urgent. A number of 99mTc radiopharmaceuticals which are already in general use have been studied in various chromatographic procedures which might potentially provide adequate quality control. The comparative effectiveness of each of these chromatographic procedures for the accurate quality control of each radiopharmaceutical may be readily observed and an adequate procedure decided upon. The practical ease of handling and the technical skills necessary for the accurate handling of each chromatographic system is discussed. It is recommended that quality control of 99mTc-albumin be done on a Sephadex G50 column and that of 99mTc-DTPA be done with thin-layer silica gel chromatography in both saline and acetone or butyl acetate. The quality-control procedure for 99mTc-polyphosphate is shown to be dependent on the commercial kit which is used. Two such commercial kits are discussed.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
C. G. Tankersley, J. A. Shank, S. E. Flanders, S. E. Soutiere, R. Rabold, W. Mitzner, and E. M. Wagner
Changes in lung permeability and lung mechanics accompany homeostatic instability in senescent mice
J Appl Physiol, October 1, 2003; 95(4): 1681 - 1687.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
W. M. Foster and E. M. Wagner
Bronchial edema alters 99mTc-DTPA clearance from the airway surface in sheep
J Appl Physiol, December 1, 2001; 91(6): 2567 - 2573.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. M. Wagner and W. M. Foster
Interdependence of bronchial circulation and clearance of 99mTc-DTPA from the airway surface
J Appl Physiol, April 1, 2001; 90(4): 1275 - 1281.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
W. M. Foster and A. N. Freed
Regional clearance of solute from peripheral airway epithelia: recovery after sublobar exposure to ozone
J Appl Physiol, February 1, 1999; 86(2): 641 - 646.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
W. M. Foster, P. T. Stetkiewicz, and A. N. Freed
Retention of soluble 99mTc-DTPA in the human lung: 24-h postdeposition
J Appl Physiol, April 1, 1997; 82(4): 1378 - 1378.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1973 by the Society of Nuclear Medicine.